tetano
Editor, Senior Moderator
BMC Pulm Med
. 2021 Mar 24;21(1):102.
doi: 10.1186/s12890-021-01453-2.
An unexpected case of recurrence of pulmonary embolism in a patient recovered from COVID19 in full regimen dose of direct oral anticoagulant drug
Emilia D'Elia[SUP] 1 [/SUP], Mauro Gori[SUP] 2 [/SUP], Aurelia Grosu[SUP] 2 [/SUP], Annamaria Iorio[SUP] 2 [/SUP], Ferdinando Luca Lorini[SUP] 2 [/SUP], Anna Falanga[SUP] 2 3 [/SUP], Fabiano Di Marco[SUP] 2 4 [/SUP], Michele Senni[SUP] 2 [/SUP]
Affiliations
Abstract
Background: Coronavirus Disease 2019 (COVID-19) is a pandemic affecting all countries in the world. Italy has been particularly afflicted by the health emergency, and since the peak phase has passed, major concern regarding medium to long term complications due to COVID-19 is arising. Little is known in literature regarding thromboembolic complications once healed after COVID-19.
Case presentation: A 51-year-old patient recovered from COVID-19 pneumonia complicated by pulmonary embolism (PE) came to the hospital for palpitations and chest pain. Although he was on treatment dose of direct oral anticoagulation (DOAC), massive recurrent PE was diagnosed.
Conclusion: In the early post COVID-19 era, the question remains regarding the efficacy of DOACs in COVID-19 patients.
Keywords: COVID-19; Case Report; Complications; Direct Oral Anticoagulation; Pulmonary Embolism.
. 2021 Mar 24;21(1):102.
doi: 10.1186/s12890-021-01453-2.
An unexpected case of recurrence of pulmonary embolism in a patient recovered from COVID19 in full regimen dose of direct oral anticoagulant drug
Emilia D'Elia[SUP] 1 [/SUP], Mauro Gori[SUP] 2 [/SUP], Aurelia Grosu[SUP] 2 [/SUP], Annamaria Iorio[SUP] 2 [/SUP], Ferdinando Luca Lorini[SUP] 2 [/SUP], Anna Falanga[SUP] 2 3 [/SUP], Fabiano Di Marco[SUP] 2 4 [/SUP], Michele Senni[SUP] 2 [/SUP]
Affiliations
- PMID: 33761886
- DOI: 10.1186/s12890-021-01453-2
Abstract
Background: Coronavirus Disease 2019 (COVID-19) is a pandemic affecting all countries in the world. Italy has been particularly afflicted by the health emergency, and since the peak phase has passed, major concern regarding medium to long term complications due to COVID-19 is arising. Little is known in literature regarding thromboembolic complications once healed after COVID-19.
Case presentation: A 51-year-old patient recovered from COVID-19 pneumonia complicated by pulmonary embolism (PE) came to the hospital for palpitations and chest pain. Although he was on treatment dose of direct oral anticoagulation (DOAC), massive recurrent PE was diagnosed.
Conclusion: In the early post COVID-19 era, the question remains regarding the efficacy of DOACs in COVID-19 patients.
Keywords: COVID-19; Case Report; Complications; Direct Oral Anticoagulation; Pulmonary Embolism.